XML 42 R14.htm IDEA: XBRL DOCUMENT v3.20.1
Debt
3 Months Ended
Mar. 28, 2020
Debt Disclosure [Abstract]  
Debt
7
 Debt
In November 2017, the Company entered into a credit agreement (the “2017 Credit Agreement”) that provides for a $1.5 billion revolving facility and a $300 million term loan. The revolving facility and term loan both mature on November 30, 2022 and require no scheduled prepayments before that date.
The interest rates applicable to the 2017 Credit Agreement are, at the Company’s option, equal to either the alternate base rate (which is a rate per annum equal to the greatest of (1) the prime rate in effect on such day, (2) the Federal Reserve Bank of New York Rate on such day plus 1/2 of 1% per annum and (3) the adjusted LIBO rate on such day (or if such day is not a business day, the immediately preceding business day) for a deposit in U.S. dollars with a maturity of one month plus 1% per annum) or the applicable 1, 2, 3 or 6 month adjusted LIBO rate or EURIBO rate for Euro-denominated loans, in each case, plus an interest rate margin based upon the Company’s leverage ratio, which can range between 0 and 12.5 basis points for alternate base rate loans and between 80 and 112.5 basis points for LIBO rate or EURIBO rate loans. The facility fee on the 2017 Credit Agreement ranges between 7.5 and 25 basis points per annum, based on the leverage ratio, of the amount of the revolving facility commitments and the outstanding term loan. The 2017 Credit Agreement requires that the Company comply with an interest coverage ratio test of not less than 3.50:1 as of the end of any fiscal quarter for any period of four consecutive fiscal quarters and a leverage ratio test of not more than 3.50:1 as of the end of any fiscal quarter. In addition, the 2017 Credit Agreement includes negative covenants, affirmative covenants, representations and warranties and events of default that are customary for investment grade credit facilities.
As of March 28, 2020 and December 31, 2019, the Company had a total of $960 
million and $1.1
billion, respectively, of outstanding senior unsecured notes. Interest on the fixed rate senior unsecured notes is payable semi-annually each year. Interest on the floating rate senior unsecured notes is payable quarterly. The Company may prepay all or some of the senior unsecured notes at any time in an amount not less than 10% of the aggregate principal amount outstanding, plus the applicable make-whole amount or prepayment premium for the Series H senior unsecured note. In the event of a change in control of the Company (as defined in the note purchase agreement), the Company may be required to prepay the senior unsecured notes at a price equal to 100% of the principal amount thereof, plus accrued and unpaid interest. These senior unsecured notes require that the Company comply with an interest coverage ratio test of not less than 3.50:1 for any period of four consecutive fiscal quarters and a leverage ratio test of not more than 3.50:1 as of the end of any fiscal quarter. In addition, these senior unsecured notes include customary negative covenants, affirmative covenants, representations and warranties and events of default.
The Company had the following outstanding debt at March 28, 2020 and December 31, 2019 (in thousands):
 
March 28, 2020
 
 
December 31, 2019
 
Foreign subsidiary lines of credit
  $
—  
    $
366
 
Senior unsecured notes - Series B - 5.00%, due February 2020
   
—  
     
100,000
 
Senior unsecured notes - Series E - 3.97%, due March 2021
   
50,000
     
—  
 
                 
Total notes payable and debt, current
   
50,000
     
100,366
 
Senior unsecured notes - Series E - 3.97%, due March 2021
   
—  
     
50,000
 
Senior unsecured notes - Series F - 3.40%, due June 2021
   
100,000
     
100,000
 
Senior unsecured notes - Series G - 3.92%, due June 2024
   
50,000
     
50,000
 
Senior unsecured notes - Series H - floating rate*, due June 2024
   
50,000
     
50,000
 
Senior unsecured notes - Series I - 3.13%, due May 2023
   
50,000
     
50,000
 
Senior unsecured notes - Series K - 3.44%, due May 2026
   
160,000
     
160,000
 
Senior unsecured notes - Series L - 3.31%, due September 2026
   
200,000
     
200,000
 
Senior unsecured notes - Series M - 3.53%, due September 2029
   
300,000
     
300,000
 
Credit agreement
   
940,000
     
625,000
 
Unamortized debt issuance costs
   
(4,019
)    
(4,203
)
                 
Total long-term debt
   
1,845,981
     
1,580,797
 
                 
Total debt
  $
1,895,981
    $
1,681,163
 
                 
*
Series H senior unsecured notes bear interest at a 3-month LIBOR for that floating rate interest period plus 1.25%
.
As of March 28, 2020 and December 31, 2019, the Company had a total amount available to borrow under the 2017 Credit Agreement of
 $858 million and
 
$1.2 billion
, respectively
,
 after outstanding letters of credit. The weighted-average interest rates applicable to the senior unsecured notes and credit agreement borrowings collectively were 2.90% and 3.39% at March 28, 2020 and December 31, 2019, respectively. As of March 28, 2020, the Company was in compliance with all debt covenants.
The Company and its foreign subsidiaries also had available short-term lines of credit totaling $105 million
 
at
 each of
 
March 28, 2020 and December 31, 2019, for the purpose of short-term borrowing and issuance of commercial guarantees. The weighted-average interest rate applicable to these short-term borrowings
 was
 1.48% for 
December 31, 2019. None of the Company’s foreign subsidiaries had outstanding short-term borrowings as of March 28, 2020.
As of March 28, 2020, the Company had entered into three-year interest rate cross-currency swap derivative agreements with an aggregate notional value of $560 million to hedge the variability in the movement of foreign currency exchange rates on a portion of its Euro-denominated net asset investments.